MIRA
INFORM REPORT
|
Report Date : |
08.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
PRADIPKUMAR PHARMA PRIVATE LIMITED |
|
|
|
|
Formerly Known As : |
PRADIPKUMAR AND COMPANY (PHARMA) PRIVATE LIMITED |
|
|
|
|
Registered Office : |
701, 7th Floor, Arun
Chambers, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2011 |
|
|
|
|
Date of Incorporation : |
26.08.1991 |
|
|
|
|
Com. Reg. No.: |
11-063069 |
|
|
|
|
Capital Investment / Paid-up Capital : |
Rs.30.000 Millions |
|
|
|
|
CIN No.: [Company
Identification No.] |
U99999MH1991PTC063069 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMP10049E |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturers of Pharmaceutical
Formulations and Bulk drugs. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B (34) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
|
|
|
|
Maximum Credit Limit : |
USD 190000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established
company having moderate track. The company is progressing. Trade relations are
reported as fair. Business is active. Payments are reported to be slow but
correct. The company can be considered for small to mediocre business dealings at usual trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
701, 7th Floor, Arun
Chambers, |
|
Tel. No.: |
91-22-22082069/ 22081770/
22085118/ 22085119/ 22332345/ 40312222/ (Resi) 3872936 / 40312222 |
|
Fax No.: |
91-22-22085113/ 22082069/
40312200 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
Gala No. 5/6, Manish Compound, Rehnal Village, Anjur Phata, Thane Road, Bhiwandi – 421308, Maharashtra, India |
DIRECTORS
As on 30.09.2011
|
Name : |
Mr. Pradipkumar Ramanlal Shah |
|
Designation : |
Managing Director |
|
Address : |
1301, Veena Apartment, 198, |
|
Date of Birth/Age : |
05.04.1947 |
|
Qualification : |
B. Com |
|
Date of Appointment : |
26.08.1991 |
|
DIN No.: |
01147637 |
|
|
|
|
Name : |
Mr. Dinesh Ramanlal Shah |
|
Designation : |
Whole-Time Director |
|
Address : |
8, Songadh Apartments, 4th
Floor, 48, |
|
Date of Birth/Age : |
22.05.1959 |
|
Qualification : |
B. A. |
|
Date of Appointment : |
01.04.1995 |
|
DIN NO. |
01147934 |
|
|
|
|
Name : |
Mr. Umesh Ramanlal Shah |
|
Designation : |
Whole Time Director |
|
Address : |
22 Suraj Apartments, 274, |
|
Date of Birth/Age : |
25.06.1957 |
|
Qualification : |
B. Com |
|
Date of Appointment : |
01.04.1995 |
|
DIN No.: |
01147872 |
|
|
|
|
Name : |
Mr. Dhiren Ramanlal Shah |
|
Designation : |
Director |
|
Address : |
1, Ravindra Kutir, 29-B, |
|
Date of Birth/Age : |
27.10.1955 |
|
Date of Appointment : |
01.04.1995 |
|
DIN No.: |
01222891 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2011
|
Names of Shareholders |
|
No. of Shares |
|
|
|
|
|
R. Pradipkumar Ramanlal |
|
21120 |
|
Pradipkumar R. Shah (HUF) |
|
19800 |
|
R. Pradipkumar Ramanlal Joint with P. Pravina Pradipkumar |
|
26440 |
|
P. Pravina Pradipkumar Joint with R. Pradipkumar Ramanlal |
|
18200 |
|
Ramanlal Shah (HUF) |
|
19140 |
|
Nipa D. Shah Joint with Dinesh
R. Shah |
|
24800 |
|
Dinesh R. Shah Joint with Nipa
D. Shah |
|
27100 |
|
Dinesh R. Shah (HUF) |
|
13200 |
|
Dinesh R. Shah (HUF) |
|
13200 |
|
Alok Shah Joint with Dhiren Shah
|
|
13200 |
|
Dhiren R. Shah Joint with Tejal Shah |
|
20500 |
|
Tejal Shah Joint with Dhiren
Shah |
|
18200 |
|
Umesh Shah Joint with Priti Shah
|
|
20500 |
|
Priti Shah Joint with Umesh Shah |
|
18200 |
|
Deep Shah Joint with Umesh Shah |
|
13200 |
|
Umesh R. Shah (HUF) |
|
13200 |
|
Total |
|
300000 |
List of Allottees
As on 09.02.2012
|
Name of Allottees |
|
No. of Shares
Allotted |
|
|
|
|
|
Pradipkumar R. Shah |
|
10560 |
|
Pradipkumar R. Shah (HUF) |
|
9900 |
|
Pradipkumar R. Shah Joint
with Pravina P. Shah |
|
13220 |
|
Pravina P. Shah Joint
with Pradipkumar R. Shah |
|
9100 |
|
Ramanlal Shah (HUF) |
|
9570 |
|
Nipa D. Shah Joint with Dinesh
R. Shah |
|
12400 |
|
Dinesh R. Shah Joint with Nipa
D. Shah |
|
13550 |
|
Dinesh R. Shah (HUF) |
|
6600 |
|
Dhiren R. Shah (HUF) |
|
6600 |
|
Alok Shah Joint with Dhiren Shah |
|
6600 |
|
Dhiren R. Shah Joint with Tejal D. Shah |
|
10250 |
|
Tejal D. Shah Joint with Dhiren
R. Shah |
|
9100 |
|
Umesh R. Shah Joint with Priti
U. Shah |
|
10250 |
|
Priti U. Shah Joint with Umesh R. Shah |
|
9100 |
|
Deep U. Shah Joint with Umesh R.
Shah |
|
6600 |
|
Umesh R. Shah (HUF) |
|
6600 |
|
Total |
|
150000 |
As on 30.09.2011
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturers of Pharmaceutical Formulations
and Bulk drugs. |
||||||||||||||
|
|
|
||||||||||||||
|
Products : |
·
Phenelephrine ·
Sulphamethoxazole ·
Metronidazole ·
Ofloxacin USP 24 · Tetracpy Cycline HCL · Norfloxacin USP 24 ·
Aerosil 200, Degusa ·
Albendazole CP, ·
·
·
Analgin Dab10, ·
Aspartham USP24, ·
Aspartam USP24, ·
·
Atropine Methyl Nitrate, German · Atropine Sulphate IP/BP/USP, German ·
Atropine Sulphate IP/BP/USP, German ·
Tropine Sulphate IP/BP/USP, German ·
Atropine Sulphate IP/BP/USP, ·
Atropine Sulphate IP/BP/USP, ·
·
·
C. P. Maleate I.P., ·
Calcium D. Pantothenate BP, ·
Ntothenate BP, ·
Calcium Pantothenate Feed 45%, ·
Calcium Lactate BP98, ·
·
Chlomipramine HCL, ·
Chloramphenicol I. P., |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Bankers : |
·
Bank of India,
Bullion Exchange Branch, 185 Sheikh Memon Street, Kalbadevi Road, Mumbai –
400002, Maharashtra, India ·
HDFC Bank Limited |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
B. B. Lakdawala and Company Chartered Accountants |
|
Address : |
|
|
Tel. No.: |
91-22-26201767 |
|
Telfax No.: |
91-22-26236706 |
|
PAN No.: |
AAAPL7669Q |
|
|
|
|
Associates/Subsidiaries : |
Pradipkumar and Company Address : Shreeji Bhuwan, 2nd Floor, Mangaldas Road, Lohar Chawl,
Mumbai – 400002, Maharashtra, India Line of Business : Manufacturers, importers, exporters and traders of
pharmaceuticals |
CAPITAL STRUCTURE
As on 30.09.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
450000 |
Equity Shares |
Rs.100/- each |
Rs.45.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
300000 |
Equity Shares |
Rs.100/- each |
Rs.30.000 Millions |
|
|
|
|
|
After 30.09.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
450000 |
Equity Shares |
Rs.100/- each |
Rs.45.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital:
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
450000 |
Equity Shares |
Rs.100/- each |
Rs.45.000 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
30.000 |
30.000 |
15.000 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
17.744 |
8.638 |
19.402 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
47.744 |
38.638 |
34.402 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
19.883 |
7.285 |
3.004 |
|
|
2] Unsecured Loans |
86.220 |
81.247 |
56.429 |
|
|
TOTAL BORROWING |
106.103 |
88.532 |
59.433 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
153.847 |
127.170 |
93.835 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
4.032 |
4.255 |
3.278 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.215 |
0.204 |
0.153 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
45.113 |
49.733 |
27.389 |
|
|
Sundry Debtors |
161.681 |
114.502 |
111.594 |
|
|
Cash & Bank Balances |
4.722 |
5.764 |
4.354 |
|
|
Other Current Assets |
10.131 |
7.897 |
0.878 |
|
|
Loans & Advances |
4.275 |
0.582 |
1.019 |
|
Total
Current Assets |
225.922 |
178.478 |
145.234 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
61.655 |
45.590 |
42.158
|
|
|
Other Current Liabilities |
14.667 |
10.128 |
12.672 |
|
|
Provisions |
0.000 |
0.049 |
0.000 |
|
Total
Current Liabilities |
76.322 |
55.767 |
54.830 |
|
|
Net Current Assets |
149.600 |
122.711
|
90.404 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
153.847 |
127.170 |
93.835 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
516.496 |
459.906 |
380.490 |
|
|
|
Other Income |
13.113 |
14.091 |
|
|
|
|
TOTAL (A) |
529.609 |
473.997 |
380.490 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Office Expenses |
|
|
|
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL (B) |
501.294 |
453.897 |
358.592 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
28.315 |
20.100 |
21.898 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
11.478 |
10.482 |
6.578 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
16.837 |
9.618 |
15.320 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
1.132 |
0.903 |
0.681 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
15.705 |
8.715 |
14.639 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
5.550 |
2.724 |
5.436 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
10.155 |
5.991 |
9.203 |
|
|
|
|
|
|
|
|
|
|
PREVIOUS YEARS’ BALANCE
BROUGHT FORWARD |
8.338 |
19.102 |
16.654 |
|
|
|
|
|
|
|
|
|
|
APPROPRIATIONS |
|
|
|
|
|
|
|
Bonus Shares |
0.000 |
5.000 |
5.000 |
|
|
|
Dividend |
0.000 |
1.500 |
1.500 |
|
|
|
Tax on Dividend |
0.000 |
0.255 |
0.255 |
|
|
BALANCE CARRIED
TO THE B/S |
18.493 |
8.338 |
19.102 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
33.96 |
19.97 |
61.35 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
1.92 |
1.26
|
2.42 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
3.04
|
1.89 |
NA |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
6.83 |
4.77
|
9.86 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.33 |
0.23
|
0.43 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
3.82 |
3.73
|
3.32 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.96 |
3.20
|
2.65
|
LOCAL AGENCY FURTHER INFORMATION
|
Check List by Info
Agents |
Available in Report
(Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
No |
|
5) Type of Business |
Yes |
|
6) Line of Business• |
Yes |
|
7) Promoter’s background |
Yes |
|
8) No. of employees |
No |
|
9) Name of person contacted |
No |
|
10) Designation of contact person |
No |
|
11) Turnover of firm for last three years |
Yes |
|
12) Profitability for last three years |
Yes |
|
13) Reasons for variation <> 20% |
-- |
|
14) Estimation for coming financial year |
No |
|
15) Capital in the business |
Yes |
|
16) Details of sister concerns |
Yes |
|
17) Major suppliers |
No |
|
18) Major customers |
No |
|
19) Payments terms |
No |
|
20) Export / Import details (if applicable) |
No |
|
21) Market information |
-- |
|
22) Litigations that the firm / promoter |
-- |
|
23) Banking Details |
Yes |
|
24) Banking facility details |
Yes |
|
25) Conduct of the banking account |
-- |
|
26) Buyer visit details |
-- |
|
27) Financials, if provided |
Yes |
|
28) Incorporation details, if applicable |
Yes |
|
29) Last accounts filed at ROC |
Yes |
|
30) Major Shareholders, if available |
Yes |
OPERATING AND
FINANCIAL RESULTS:
The Company’s Sales during the year amounted to Rs. 516.496 Millions
compared to Rs. 459.906 Millions in the previous year thus registering an
increase by 13.30% and other income amounted to Rs.4.276 Millions The same
enabled the Company to reflect net profit of Rs.10.155 Millions after making
provision for tax amounting to Rs 5.550 Millions compared to Net Profit of Rs
5.991 Millions in the previous year.
NOTE:
The Registered Office of the
company has been shifted from Shreeji Bhuwan, 2nd Floor,
BANKERS CHARGES
REPORT AS PER REGISTRY
|
Corporate
identity number (CIN) Foreign company registration number |
U99999MH1991PTC063069 |
|
Name of the
Company |
PRADIPKUMAR PHARMA PRIVATE LIMITED |
|
Address |
701, 7th Floor, Arun
Chambers, |
|
This form is for |
Modification of Charge |
|
Charge
identification (ID) number of the charge to be modified |
90163097 |
|
Type of Charge |
Movable Property
(not being pledge) Book Debts |
|
Particulars of
the charge holder |
Bank of India, Bullion Exchange
Branch, 185 Sheikh Memon Street, Kalbadevi Road, Mumbai – 400002,
Maharashtra, India |
|
Nature or
description of the instrument(s) creating or modifying the charge |
Supplemental
Deeds of Hypothecation dated 01.01.2011 |
|
Date of the
instrument creating or modifying the charge |
01.01.2011 |
|
Amount secured by
the charge |
Rs.90.000
Millions |
|
Brief particulars
of the principal terms and conditions and extent and operation of the charge |
Rate of
Interests: Rate of interest
3 % over base rate presently 12.50% p.a. Terms of
Repayments: On Demand Margin: CC Stock -25% Book Debts - 30% Import LC DP -10% Import LC DA 180
Days - 10% Extent and
operation of the charge: As per Bank of India guidelines from time to time |
|
Short particulars
of the property charged (including location of the property) |
All types of drugs
and pharmaceuticals, chemicals etc. All the present
and future book debts, outstanding money receivables, claims bills which are
now due and owing or which may at any time hereafter during the continuance
of this security become due. |
|
Date of instrument
modifying the charge |
27.01.2010 |
|
Particular of the
present modification |
Charge enhanced
from Rs. 65.000 Millions to Rs. 90.000 Millions |
FIXED ASSETS:
·
Furniture and Fixtures
·
Computer
·
Fax Machines
·
Mobile Phone
·
Tea Mixture Machine
·
Air Conditioner
·
Refrigerator
·
Stabilizers
·
Weighing Scale
·
Vehicles
·
UPS System
·
Locking System
·
Telephone
Instruments
·
Cold Storage
·
Trolley Hydraulic Hand Pallet Truck Cap
Profile:
Subject was established in the
year 1958 and is one of the senior and most experienced and reputed
organisations in the Pharma Industry all over
Known for its excellent service and time bound delivery schedule has earned the
group company small to biggest clients all over India and the honesty and
excellent financial management has earned the company its reputation,
distribution and marketing for many large bulk manufacturing companies of India
and overseas.
The group companies have been
ranked an AAA by its banker and have met all its financial commitments in
They have business Associates in prime cities in
The company was keeping the clients informed on every product by monthly market report 5000 copies, which was being circulated all over India for years together. And now with the changing time here is the sight where with better Scientific approach to keep all the customer informed on the rates of most of their items with unique feature of the graphical presentation of the rate trends and the numeric rates foe few items. The inquiry of each clients for any items not appearing in the list also will be replied as early as possible.
The company is being managed by
the most experienced directors directly interacting with the clients as every good
client is equally important for the company.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.15 |
|
|
1 |
Rs.85.22 |
|
Euro |
1 |
Rs.69.24 |
INFORMATION DETAILS
|
Report Prepared
by : |
BSN |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
4 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
34 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.